DePuy Synthes' Velys robot receives FDA clearance for unicompartmental knee replacements.

DePuy Synthes, a Johnson & Johnson company, receives FDA 510(k) clearance for Velys robot, allowing it to be used in unicompartmental knee replacements. The device, designed for medial and lateral procedures, assists surgeons with implant placement without a CT scan. Velys has been cleared for total knee replacements in 20 markets and has been used in over 55,000 procedures.

June 07, 2024
3 Articles